- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04194970
Monitoring of Weight Bearing Protocols Via Mobile Application and Pressure Sensors.
The Effects of Monitoring Weight Bearing Protocols Following Lower Extremity Surgeries Via Mobile Application and Pressure Sensors.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey
- Marmara University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with a symptomatic osteochondral lesion of the Talus.
- Magnetic resonance of the ankle showing osteochondral injury of a single talus
- People who can use smart phone (andoid or ios)
Exclusion Criteria:
- Recurrent osteochondral lesions of the talus
- Multiple osteochondral lesions
- Severe ankle instability, requiring open repair
- History of a previous foot or ankle surgery of the ipsilateral foot
- Having a systematic disorders like Diabetes Mellitus, Rheumatoid arthritis etc.
- Inability to return to the surgery site to practice long-term follow-up evaluations or lack of readiness to complete the indicated evaluation forms.
- Patients with a qualitative or quantitative commitment that prevents consent or assent their participation in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group I (monitoring with live-feedback system)
WBM smart insole system is a product that can monitor the pressure under the foot and provide live feedback (if this option activated) to the user in case of exceeding the specified limits.
Its components are insole with pressure sensors and mobile applications (IOS, Android).
Post-operative patients (osteochondral lesion of the talus) will be monitored with the WBM smart insole system in case live feedback is turned on.
We aimed to ensure the compliance of patients to specified weight bearing limits.
We will follow up this grup for 6 weeks periods with WBM smart insole system.
Pre-op.
and post-op 6 week, we evaluate the patients in case of ankle function, pain with The American Orthopaedic Foot & Ankle Society (AOFAS) Scoring.
Also we will monitor the compliance success of patients with WBM smart insole system during 6 week.
The relationship with compliance to weight bearing success and AOFAS scores will be evaluate.
|
Weight Bearing Protocol (Duration: Post-Op. 6 week)
|
Active Comparator: Group II (monitoring without live feedback)
The post-operative patients (osteochondral lesion of talus), follow-up with product in live-feedback closed condition. After surgery, we will educate the patients about weight bearing protocol on post-op first day and post op 3 week. The protocol is " first 3 weeks, %0 body weight bearing (BWB), second 3 weeks between %10-%20 BWB". Patients' compliance to BWB protocol will be monitored daily with the WBM smart insole system in case live-feedback is turned off. Pre-op and post-op 6 week, we evaluate the patients in case of ankle function, pain with The American Orthopaedic Foot & Ankle Society (AOFAS) Scoring. The relationship with compliance to weight bearing success and AOFAS scores will be evaluate. |
Weight Bearing Protocol (Duration: Post-Op. 6 week)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation the clinical recovery of osteochondral lesion of talus post operative patients.
Time Frame: pre-operative day, post-op 6 week, post-op 12 week, post-op 24 week
|
American Orthopedic Foot and Ankle Society- Ankle hindfoot scale will be used for this evaluation.
The scale includes nine items that can be divided into three sub-scales (pain, function and alignment).
Pain consists of one item with a maximal score of 40 points, indicating no pain.
Function consists of seven items with a maximal score of 50 points, indicating full function.
Alignment consists of one item with a maximal score of 10 points, indicating good alignment.
The maximal score is 100 points, indicating no symptoms or impairments.
This scale will be used for evaluation the clinical recovery of osteochondral lesion of talus post operative patients.
|
pre-operative day, post-op 6 week, post-op 12 week, post-op 24 week
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Monitoring the compliance with weight bearing protocol
Time Frame: Post-op every day for 6 weeks
|
number of times above the specified upper threshold, the number of failures to reach the specified lower threshold, percentage of steps in correct weight bearing range parameter will be monitored by the device (insole with pressure sensors)
|
Post-op every day for 6 weeks
|
Visual Analog Scale
Time Frame: Post-op every day for 6 weeks, post-op 12 week, post-op 24 week
|
Visual Analog Scale for Pain (VAS-Pain): a pain rating scale based on self-reported measures of symptoms. A 10cm line numbered from 0 to 10 represents a continuum between "no pain" (zero) and "worst pain" (ten). It can also be interpreted as a 0-to-100 points score. This scale will be used for assessment of patient's pain levels after activity and at rest |
Post-op every day for 6 weeks, post-op 12 week, post-op 24 week
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: İlkşan Demirbüken, Assoc.Prof., Marmara University
- Principal Investigator: Ender Ersin AVCI, MsC, Marmara University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 09.2019.593
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteochondral Lesion of Talus
-
Assiut UniversityNot yet recruitingOsteochondral Lesion of Talus
-
Samsung Medical CenterUnknownOsteochondral Lesion of TalusKorea, Republic of
-
Hyundai Bioland Co., Ltd.Medipost Co Ltd.CompletedChondral or Osteochondral Lesion of TalusKorea, Republic of
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Not yet recruiting
-
Barmherzige Brüder EisenstadtUnknownDegenerative Lesion of Articular Cartilage of Knee | Osteochondral Lesion of Talus
-
Southwest Hospital, ChinaUnknownOsteochondral Lesion of TalusChina
-
Rothman Institute OrthopaedicsUnknownOsteochondral Lesion of TalusUnited States
-
Geistlich Pharma AGWithdrawnChondral Defect | Osteochondral Lesion of Talus | MicrofractureUnited Kingdom
-
Peking University Third HospitalCompletedOsteochondral Lesions of the Talus
-
Peking University Third HospitalRecruitingPlatelet Rich Plasma | Osteochondral Lesion of Talus | MicrofracturesChina